PB2346: ZUMA-24: A PHASE 2, OPEN-LABEL, MULTICENTER STUDY OF AXICABTAGENE CILOLEUCEL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA GIVEN WITH CORTICOSTEROIDS IN THE OUTPATIENT SETTING

• Lori Leslie,
• Michael Tees,
• Ian W. Flinn,
• Tulio Rodriguez,
• John H. Baird,
• Abhinav Deol,
• Monica Mead,
• Carlos Bachier,
• Aaron P. Rapoport,
• Brian Mcclune,
• Daanish Hoda,
• Miguel-Angel Perales,
• Yan Zheng,
• Simone Filosto,
• Madison Davis1,
• Harry Miao,
• Jenny J. Kim,
• Olalekan O. Oluwole

Affiliations

Lori Leslie

1 Hackensack University Medical Center, Hackensack, United States

Michael Tees

2 Colorado Blood Cancer Institute, Denver, United States

Ian W. Flinn

3 SCRI – Tennessee Oncology – Nashville – Centennial, Nashville, United States

Tulio Rodriguez

4 Advocate Lutheran General Hospital, Park Ridge, United States

John H. Baird

5 City of Hope Comprehensive Cancer Center - Duarte, Duarte, United States

Abhinav Deol

6 Karmanos Cancer Institute, Detroit, United States

Monica Mead

7 University of California Los Angeles, Los Angeles, United States

Carlos Bachier

8 Methodist Hospital, San Antonio, United States

Aaron P. Rapoport

9 University of Maryland Medical Center, Baltimore, United States

Brian Mcclune

10 Huntsman Cancer Institute, Salt Lake City, United States

Daanish Hoda

11 Intermountain Healthcare, Salt Lake City, United States

Miguel-Angel Perales

12 Memorial Sloan Kettering Cancer Center, New York, United States

Yan Zheng

13 Kite, a Gilead Company, Santa Monica, United States

Simone Filosto

13 Kite, a Gilead Company, Santa Monica, United States

Madison Davis1

3 SCRI – Tennessee Oncology – Nashville – Centennial, Nashville, United States

Harry Miao

13 Kite, a Gilead Company, Santa Monica, United States

Jenny J. Kim

13 Kite, a Gilead Company, Santa Monica, United States

Olalekan O. Oluwole

14 Vanderbilt University Medical Center, Nashville, United States